Comparative Pharmacology
Head-to-head clinical analysis: DIANEAL PD 1 W DEXTROSE 3 5 IN PLASTIC CONTAINER versus INPERSOL LC LM W DEXTROSE 2 5 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DIANEAL PD 1 W DEXTROSE 3 5 IN PLASTIC CONTAINER versus INPERSOL LC LM W DEXTROSE 2 5 IN PLASTIC CONTAINER.
DIANEAL PD-1 W/ DEXTROSE 3.5% IN PLASTIC CONTAINER vs INPERSOL-LC/LM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dianeal PD-1 with dextrose 3.5% is a peritoneal dialysis solution that uses dextrose as an osmotic agent to create an osmotic gradient across the peritoneal membrane, facilitating the removal of waste products (urea, creatinine) and excess fluid from the blood into the dialysate.
The mechanism of action of INPERSOL-LC/LM W/ DEXTROSE 2.5% is based on peritoneal dialysis. Dextrose creates an osmotic gradient across the peritoneal membrane, facilitating the removal of waste products (e.g., urea, creatinine) and excess fluid from the blood into the dialysate. Lactate or low magnesium buffer corrects metabolic acidosis by providing bicarbonate precursors.
2-3 L intraperitoneally, dwell time 4-6 hours, 4-5 exchanges per day
Intraperitoneal administration: 2 liters of 2.5% dextrose solution per exchange, typically 4-5 exchanges per day, as part of continuous ambulatory peritoneal dialysis (CAPD). For automated peritoneal dialysis (APD): 2 liters per cycle, 4-6 cycles per night, with a daytime dwell as prescribed.
None Documented
None Documented
Glucose: 1.5–2 hours (intraperitoneal administration leading to systemic absorption); clinical context: prolonged in renal impairment due to decreased clearance of metabolic products, but glucose itself is rapidly metabolized.
Intraperitoneal dextrose has a terminal elimination half-life of approximately 1-2 hours, reflecting rapid absorption from the peritoneal cavity followed by systemic metabolism and distribution.
Renal (virtually 100% of absorbed dextrose and metabolites); peritoneal dialysis removes glucose and metabolic byproducts, but significant elimination occurs via transperitoneal absorption into systemic circulation followed by renal excretion (in patients with residual renal function). In anuric patients, glucose is metabolized and eliminated as CO2 and water, with minimal direct excretion.
Primarily renal elimination through peritoneal dialysis; approximately 60-80% of dextrose absorbed is metabolized to CO2 and water, with the remainder eliminated via the kidneys. Non-dextrose components are removed via peritoneal dialysis outflow.
Category C
Category C
Peritoneal Dialysis Solution
Peritoneal Dialysis Solution